Medical Device — Sacral Neuromodulation

Axonics

R&M supported Axonics across SOX 404 program design and testing through multiple fiscal years, ASC 326 CECL implementation, the Contura acquisition purchase accounting, and ongoing SEC compliance.

Industry	Medical Device — Sacral Neuromodulation
Market	Acquired by Boston Scientific
Location	Irvine, CA
Focus	ASC 805 Acquisition, SOX 404, ASC 326 CECL, Contura Acquisition

Engagement summary

Client Background

Axonics was a publicly traded medical-device company that developed sacral neuromodulation systems, ultimately acquired by Boston Scientific in 2024.

Engagement Scope

R&M supported Axonics across SOX 404 program design and testing through multiple fiscal years, ASC 326 CECL implementation, the Contura acquisition purchase accounting, and ongoing SEC compliance.

Services Provided

SOX 404 control design, documentation, and testing
ASC 326 CECL adoption and methodology
ASC 805 purchase accounting — Contura acquisition
Professional consulting and SEC compliance

Focus areas

ASC 805 Acquisition SOX 404 ASC 326 CECL Contura Acquisition

All case studies Discuss a similar engagement